Pharmacological interactions of anti-inflammatory-analgesics in odontology [PDF]
In this second article we describe the more interesting pharmacological interactions in dental practice based on the prescription of analgesic narcotics, paracetamol and non-selective non-steroid anti-inflammatory drugs (NSAI) (which inhibit ...
Calvo Guirado, José Luis +3 more
core
Polymorphismen des Cytochrom P 450 2D6 und ihr Einfluss auf den Erfolg der Psychopharmakotherapie.
Die hier vorliegende Arbeit untersucht den Einfluss der Polymorphismen des Cytochrom P4502D6 auf den Therapieverlauf, Wirkungen und Nebenwirkungen einer verabreichten Psychopharmakotherapie. Hierzu werden im experimentellen Teil der Arbeit neue Analysemethoden entwickelt, um die wichtigsten der bisher beschriebenen Polymorphismen des CYP2D6-Gens in ...
openaire +1 more source
Solanidine-derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients. [PDF]
Sarömba JA +9 more
europepmc +2 more sources
Assessing Cytochrome P450 Drug Interaction Risk for Dordaviprone Using Physiologically Based Pharmacokinetic Modeling. [PDF]
Jaiswal S +6 more
europepmc +1 more source
CYP2D6 Genotype and Primaquine Treatment in Patients with Malaria, Venezuela. [PDF]
Pacheco C +7 more
europepmc +1 more source
CYP2D6-inhibiting drugs and risk of fall injury after newly initiated therapy with beta-blockers-a register-based case-crossover study. [PDF]
Leander K +4 more
europepmc +1 more source
A Complete Picture of the <i>CYP2D6</i> Heterogeneity in Northeastern Italian Genetic Isolates. [PDF]
Tesolin P +7 more
europepmc +1 more source
How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil. [PDF]
Puça MCSB +8 more
europepmc +1 more source
Metabolism of Cannabidiol in Respiratory-Associated Cells and HepG2-Derived Cells and Molecular Docking of Cannabidiol and Its Metabolites with CYP Enzymes and Cannabinoid Receptors. [PDF]
Tongkanarak K +5 more
europepmc +1 more source
Optimized <i>Ginkgo biloba</i> extract EGb 761<sup>®</sup>: boosted therapeutic benefits with minimized CYP enzyme interference. [PDF]
Kwon S, Jeong S, Lee S.
europepmc +1 more source

